Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Endotone is a proprietary Ayurvedic formulation developed by Charak Pharma for the management of endometriosis and associated symptoms such as dysmenorrhea (painful periods), dyspareunia (painful intercourse), and pelvic pain. It is composed of a synergistic blend of traditional herbs, including Musta (Cyperus rotundus), Haridra (Curcuma longa), Lodhra (Symplocos racemosa), and Ashwagandha (Withania somnifera). Endotone works by delaying and stopping the proliferation of endometrial cells outside the uterus, reducing inflammation, balancing female hormones, and alleviating emotional distress and pain. It is also used to support uterine health, regulate menstrual cycles, and improve fertility potential in women affected by endometrial imbalances.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Endotone.